FDC Ltd receives EIR from USFDA for Manufacturing Facility at Waluj

FDC Ltd had earlier announced regarding the U.S. Food and Drug Administration (FDA) inspection at company's manufacturing facility located at B-8 MIDC Industrial Area, Waluj District, Aurangabad, Maharashtra State, from 6th February 2023 to 12th February 2023. FDA has determined that the inspection classification of this facility is "no action indicated" ("NAI"). Based on this inspection, this facility is considered to be in an acceptable state of compliance with regards to current good manufacturing practice (CGMP).

FDA has concluded that this inspection is ''closed'' and a copy of the narrative portion of the Establishment Inspection Report (EIR) has been issued.

Shares of FDC Limited was last trading in BSE at Rs. 308.80 as compared to the previous close of Rs. 303.95. The total number of shares traded during the day was 11959 in over 463 trades.

The stock hit an intraday high of Rs. 309.50 and intraday low of 302.00. The net turnover during the day was Rs. 3657062.00.

Source : Equity Bulls

Keywords

FDC INE258B01022 USFDA Inspection Waluj EIR